Defining a Role for Liver Myeloid Cells in Viral Persistence under ART
定义肝髓细胞在 ART 下病毒持续存在中的作用
基本信息
- 批准号:10527635
- 负责人:
- 金额:$ 46.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:AIDS/HIV problemAddressAdoptedAllelesAnatomyAntibodiesAreaBlood specimenCD4 Positive T LymphocytesCell CompartmentationCell membraneCellsCellular TropismCharacteristicsClinicalDiscriminationDisease remissionExhibitsGenetic PolymorphismGenomeHIVHIV-1Immune systemIn VitroIndividualInfectionInterruptionKupffer CellsLengthLibrariesLigandsLiverLocationMembraneMethodsMolecularMolecular CloningMyelogenousMyeloid CellsNaturePhenotypePhylogenetic AnalysisPlasmaPlasma CellsPolymeraseProvirusesRecombinantsResearchResourcesRoleSamplingStructureTissuesTransplantationVariantViralViral reservoirViremiaVirionVirusantiretroviral therapydesigninsightmacrophagemolecular clocknovelnovel strategiespersonalized approachviral rebound
项目摘要
The pursuit of a cure for HIV-1 infection is founded on the hypothesis that reservoirs that support viral persistence
are amenable to elimination. As such, most of the research on HIV-1 cure and remission has centered on
identifying the dynamics of CD4+ T cell reservoirs as well as on approaches to eliminate them. We recently
presented evidence that following analytic treatment interruption (ATI), rebounding viremia comprised virions
that were highly macrophage tropic. Through the use of a novel immunoaffinity enrichment method, we further
demonstrated that macrophage-tropic viruses in post-ATI plasma have a myeloid cell origin [1]. These
observations define myeloid cells as a reservoir under suppressive ART and that these reservoirs require
consideration in the design of viral remission and cure strategies
The myeloid compartments that house HIV-1 reservoirs under ART are unkown. However, the approaches we
developed have the capacity to yield this information. Those approaches hinge upon our demonstration that
virion membranes are derived from the host cell plasma membrane and as such, virions harbor ligands that
inform on their host cell of origin. We will adopt these approaches to address the long-standing issue of whether
Kupffer Cells in the liver, which is the largest myeloid compartment of the immune system, serve as viral
reservoirs in the face of suppressive ART. Our objectives are:
Aim1: Identify host cell ligands on virions derived from primary Kupffer cells that enable
immunoaffinity isolation of virions with a Kupffer cell origin in post ATI-plasma.
Aim 2: Derive libraries of full length viral envelopes from liver tissue of HIV-1-infected individuals
and assess their cellular tropism and dynamics by high-throughput viral phenotyping and Molecular
Clock analysis, respectively.
Aim 3: Employ liganded virion capture and high discrimation Taq (HiDi Taq) polymerase-directed
allele amplification to assess whether virions in tissue-matched plasma originate from Kupffer cells and
whether immunocaptured virions from plasma and proviruses from liver tissue exhibit related virological
characteristics and phylogenetic structures.
This proposal leverages important clinical resources that will be used to define whether Kupffer cells
serve as viral reservoirs of HIV-1. The information derived from this proposal will provide the rationale for the
identification of tailored approaches to eliminate myeloid reservoirs within the liver and other myeloid
compartments.
对HIV-1感染治愈的追求是建立在这样一种假设之上的,即支持病毒持续存在的宿主
是可以被消灭的因此,大多数关于HIV-1治愈和缓解的研究都集中在
确定CD4 + T细胞库的动态以及消除它们的方法。我们最近
提出的证据表明,分析治疗中断(ATI)后,反弹病毒血症包括病毒粒子
它们是高度嗜巨噬细胞的。通过使用一种新的免疫亲和富集方法,我们进一步
证明ATI后血浆中的嗜巨噬细胞病毒具有髓样细胞来源[1]。这些
观察将髓系细胞定义为抑制性ART下的储库,并且这些储库需要
设计病毒缓解和治愈策略时的考虑
在ART下容纳HIV-1储库的髓样区室是未知的。然而,我们的方法
发达国家有能力提供这些信息。这些方法取决于我们的证明,
病毒体膜来源于宿主细胞质膜,因此,病毒体携带配体,
告知其宿主细胞来源。我们会采用这些方法,以解决长期存在的问题,
肝脏中的库普弗细胞是免疫系统中最大的髓样区室,
我们的目标是:
目的1:鉴定来源于原代库普弗细胞的病毒体上的宿主细胞配体,
ATI后血浆中库普弗细胞来源的病毒粒子的免疫亲和分离。
目的2:从HIV-1感染者的肝组织中获得全长病毒包膜文库
并通过高通量病毒表型分析和分子生物学方法评估其细胞向性和动力学。
时钟分析。
目的3:采用配体病毒粒子捕获和高分辨Taq(HiDi Taq)聚合酶定向
等位基因扩增以评估组织匹配血浆中的病毒体是否来源于枯否细胞,
来自血浆的免疫捕获的病毒粒子和来自肝组织的前病毒是否表现出相关的病毒学特性,
特征和系统发育结构。
这项提案利用了重要的临床资源,将用于确定库普弗细胞是否
作为HIV-1的病毒库。从本提案中获得的信息将为
确定消除肝脏和其他骨髓内骨髓储库的定制方法
隔间
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mario Stevenson其他文献
Mario Stevenson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mario Stevenson', 18)}}的其他基金
Irreversible Proviral Silencing in Myeloid Cells
骨髓细胞中不可逆的前病毒沉默
- 批准号:
10705469 - 财政年份:2023
- 资助金额:
$ 46.95万 - 项目类别:
Simple Method for Screening of HIV Drug Resistance in Resource-Limited Settings
在资源有限的环境中筛查 HIV 耐药性的简单方法
- 批准号:
10384759 - 财政年份:2022
- 资助金额:
$ 46.95万 - 项目类别:
Defining a Role for Liver Myeloid Cells in Viral Persistence under ART-SUPPLEMENT 1
ART-补充 1 下定义肝髓细胞在病毒持久性中的作用
- 批准号:
10852118 - 财政年份:2022
- 资助金额:
$ 46.95万 - 项目类别:
Defining a Role for Liver Myeloid Cells in Viral Persistence under ART
定义肝髓细胞在 ART 下病毒持续存在中的作用
- 批准号:
10654037 - 财政年份:2022
- 资助金额:
$ 46.95万 - 项目类别:
Revealing HIV-1 persistence in myeloid cell reservoirs
揭示骨髓细胞储存库中 HIV-1 的持久性
- 批准号:
10709063 - 财政年份:2018
- 资助金额:
$ 46.95万 - 项目类别:
Revealing HIV-1 persistence in myeloid cell reservoirs
揭示骨髓细胞储存库中 HIV-1 的持久性
- 批准号:
10319986 - 财政年份:2018
- 资助金额:
$ 46.95万 - 项目类别:
Reservoir activity and recrudescent virus composition in HIV and SIV rebound
HIV 和 SIV 反弹中的病毒库活性和复发病毒组成
- 批准号:
10205971 - 财政年份:2017
- 资助金额:
$ 46.95万 - 项目类别:
Reservoir activity and recrudescent virus composition in HIV and SIV rebound
HIV 和 SIV 反弹中的病毒库活性和复发病毒组成
- 批准号:
9332149 - 财政年份:2017
- 资助金额:
$ 46.95万 - 项目类别:
HIV-a Persistence in Myeloid Cell Reservoirs
HIV-a 在骨髓细胞库中的持续存在
- 批准号:
9204094 - 财政年份:2016
- 资助金额:
$ 46.95万 - 项目类别:
Preclinical Development of HIV-1 Vif Antagonists - Project 2
HIV-1 Vif 拮抗剂的临床前开发 - 项目 2
- 批准号:
8723304 - 财政年份:2014
- 资助金额:
$ 46.95万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 46.95万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 46.95万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 46.95万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 46.95万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 46.95万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 46.95万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 46.95万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 46.95万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 46.95万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 46.95万 - 项目类别:
Research Grant














{{item.name}}会员




